[1] Liedtke S, Freytag EM, Bosch J, et al. Neonatal mesenchymal-like cells adapt to surrounding cells. Stem Cell Res. 2013;11(1):634-646.
[2] Vodyanik MA, Yu J, Zhang X, et al. A mesoderm- derived precursor for mesenchymal stem and endothelial cells. Cell Stem Cell. 2010;7(6):718-729.
[3] Friedenstein AJ. Precursor cells of mechanocytes. Int Rev Cytol. 1976;47:327-359.
[4] Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991;9(5):641-650.
[5] Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol. 2007;213(2):341-347.
[6] Pontikoglou C, Deschaseaux F, Sensebé L, et al. Bone marrow mesenchymal stem cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation. Stem Cell Rev. 2011;7(3): 569-589.
[7] Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell. 2008;2(4):313-319.
[8] Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317.
[9] Friedenstein A, Kuralesova AI. Osteogenic precursor cells of bone marrow in radiation chimeras. Transplantation. 1971;12(2):99-108.
[10] Lee KS, Nah JJ, Lee BC, et al. Maintenance and characterization of multipotent mesenchymal stem cells isolated from canine umbilical cord matrix by collagenase digestion. Res Vet Sci. 2013;94(1):144-151.
[11] Chang Y, Hsieh PH, Chao CC. The efficiency of Percoll and Ficoll density gradient media in the isolation of marrow derived human mesenchymal stem cells with osteogenic potential. Chang Gung Med J. 2009;32(3): 264-275.
[12] Fong CY, Peh GS, Gauthaman K, et al. Separation of SSEA-4 and TRA-1-60 labelled undifferentiated human embryonic stem cells from a heterogeneous cell population using magnetic-activated cell sorting (MACS) and fluorescence-activated cell sorting (FACS). Stem Cell Rev. 2009;5(1):72-80.
[13] Rosca AM, Burlacu A. Isolation of a mouse bone marrow population enriched in stem and progenitor cells by centrifugation on a Percoll gradient. Biotechnol Appl Biochem. 2010;55(4):199-208.
[14] Conconi MT, Burra P, Di Liddo R, et al. CD105(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential. Int J Mol Med. 2006;18(6): 1089-1096.
[15] Tondreau T, Meuleman N, Delforge A, et al. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells. 2005;23(8):1105-1112.
[16] Battula VL, Treml S, Bareiss PM, et al. Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Haematologica. 2009;94(2):173-184.
[17] Phinney DG. Isolation of mesenchymal stem cells from murine bone marrow by immunodepletion. Methods Mol Biol. 2008;449:171-186.
[18] Pierini M, Dozza B, Lucarelli E, et al. Efficient isolation and enrichment of mesenchymal stem cells from bone marrow. Cytotherapy. 2012;14(6):686-693.
[19] Xing W, Pang AM, Yao JF, et al. Efficient isolation of mesenchymal stem cells from human bone marrow by direct plating method combined with modified primary explant culture. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013;21(2):451-454.
[20] Lu LL, Liu YJ, Yang SG, et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica. 2006;91(8):1017- 1026.
[21] Maclaine SE, McNamara LE, Bennett AJ, et al. Developments in stem cells: implications for future joint replacements. Proc Inst Mech Eng H. 2013;227(3): 275-283.
[22] Mou XZ, Lin J, Chen JY, et al. Menstrual blood-derived mesenchymal stem cells differentiate into functional hepatocyte-like cells. J Zhejiang Univ Sci B. 2013; 14(11):961-972.
[23] Motaln H, Schichor C, Lah TT. Human mesenchymal stem cells and their use in cell-based therapies. Cancer. 2010;116(11):2519-2530.
[24] Wang HS, Hung SC, Peng ST, et al. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells. 2004;22(7):1330-1337.
[25] Feldmann RE Jr, Bieback K, Maurer MH, et al. Stem cell proteomes: a profile of human mesenchymal stem cells derived from umbilical cord blood. Electrophoresis. 2005;26(14):2749-2758.
[26] Rodriguez AM, Elabd C, Amri EZ, et al. The human adipose tissue is a source of multipotent stem cells. Biochimie. 2005;87(1):125-128.
[27] Lee ES, Yu SH, Jang YJ, et al. Transplantation of bone marrow-derived mesenchymal stem cells into the developing mouse eye. Acta Histochem Cytochem. 2011;44(5):213-221.
[28] Tantrawatpan C, Manochantr S, Kheolamai P, et al. Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton's jelly and their differentiation potential to neural-like cells. J Med Assoc Thai. 2013;96(9):1208-1217.
[29] Teotia PK, Hussein KE, Park KM, et al. Mouse adipose tissue-derived adult stem cells expressed osteogenic specific transcripts of osteocalcin and parathyroid hormone receptor during osteogenesis. Transplant Proc. 2013t;45(8):3102-3107.
[30] Haynesworth SE, Baber MA, Caplan AI. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone. 1992;13(1):69-80.
[31] Barry FP, Boynton RE, Haynesworth S, et al. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochem Biophys Res Commun. 1999;265(1):134-139.
[32] Tremain N, Korkko J, Ibberson D, et al. MicroSAGE analysis of 2,353 expressed genes in a single cell-derived colony of undifferentiated human mesenchymal stem cells reveals mRNAs of multiple cell lineages. Stem Cells. 2001;19(5):408-418.
[33] Jianguo W, Tianhang L, Hong Z, et al. Optimization of culture conditions for endothelial progenitor cells from porcine bone marrow in vitro. Cell Prolif. 2010;43(4): 418-426.
[34] Yan K, Wang J, Li Q. Experimental study on differentiation of adult marrow mesenchymal stem cells into vascular endothelial cells in vitro. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2007;21(1):76-80.
[35] Raida M, Heymann AC, Günther C, et al. Role of bone morphogenetic protein 2 in the crosstalk between endothelial progenitor cells and mesenchymal stem cells. Int J Mol Med. 2006;18(4):735-739.
[36] Mitchell KE, Weiss ML, Mitchell BM, et al. Matrix cells from Wharton's jelly form neurons and glia. Stem Cells. 2003;21(1):50-60.
[37] Romanov YA, Svintsitskaya VA, Smirnov VN. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells. 2003;21(1):105-110.
[38] Baffert F, Le T, Thurston G, et al. Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules. Am J Physiol Heart Circ Physiol. 2006;290(1):H107-118.
[39] Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000;109(1):235-242.
[40] Gang EJ, Jeong JA, Han S, et al. In vitro endothelial potential of human UC blood-derived mesenchymal stem cells. Cytotherapy. 2006;8(3):215-227.
[41] Wu KH, Zhou B, Lu SH, et al. In vitro and in vivo differentiation of human umbilical cord derived stem cells into endothelial cells. J Cell Biochem. 2007; 100(3): 608-616.
[42] Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7(2):211-228.
[43] Amos PJ, Shang H, Bailey AM, et al. IFATS collection: The role of human adipose-derived stromal cells in inflammatory microvascular remodeling and evidence of a perivascular phenotype. Stem Cells. 2008;26(10): 2682-2690.
[44] Konno M, Hamazaki TS, Fukuda S, et al. Efficiently differentiating vascular endothelial cells from adipose tissue-derived mesenchymal stem cells in serum-free culture. Biochem Biophys Res Commun. 2010;400(4): 461-465.
[45] Zhang Y, Li CD, Jiang XX, et al. Comparison of mesenchymal stem cells from human placenta and bone marrow. Chin Med J (Engl). 2004;117(6): 882-887.
[46] Zhang B, Adesanya TM, Zhang L, et al. Delivery of placenta-derived mesenchymal stem cells ameliorates ischemia induced limb injury by immunomodulation. Cell Physiol Biochem. 2014;34(6):1998-2006.
[47] Yin T, He S, Su C, et al. Genetically modified human placenta?derived mesenchymal stem cells with FGF?2 and PDGF?BB enhance neovascularization in a model of hindlimb ischemia. Mol Med Rep. 2015;12(4): 5093-5099.
[48] Kaviani M, Ezzatabadipour M, Nematollahi-Mahani SN, et al. Evaluation of gametogenic potential of vitrified human umbilical cord Wharton's jelly-derived mesenchymal cells. Cytotherapy. 2014;16(2):203-212.
[49] In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells. 2004; 22(7):1338-1345.
[50] Mauro A, Turriani M, Ioannoni A, et al. Isolation, characterization, and in vitro differentiation of ovine amniotic stem cells. Vet Res Commun. 2010;34 Suppl 1:S25-28.
[51] Antonucci I, Stuppia L, Kaneko Y, et al. Amniotic fluid as a rich source of mesenchymal stromal cells for transplantation therapy. Cell Transplant. 2011;20(6): 789-795. |